Contact Us Online

Social Media Karp Law Blog Twitter Facebook

Alert: You may be eligible for compensation for Injuries caused by common drugs, defective medical devices, procedures

Many patients, including large numbers of seniors, are injured each year by certain drugs - even Tylenol, Boniva and a common diabetes drug. Others suffer injury from defective devices and medical procedures, among them certain hip and knee replacements devices,and transvaginal mesh. If you believe you have sustained injury from any of the drugs, devices or procedures below, you may be entitled to compensation from the manufacturer. Contact The Karp Law Firm and we will refer you to a competent attorney who is familiar with these cases and can assist you. 

HIP REPLACEMENT DEVICES:  

There are over 20 companies that made and sold Metal on Metal Hips in the US. All have received warnings from the FDA regarding the need for post market surveillance:  

 

*Stryker Hip- The Stryker Rejuvenate Hip Implant System was released in 2009 and is a modular hip system of femoral bodies and necks. Stryker claims this product "is designed with the potential to provide: (1) Enhanced Stability; (2) Proven Modularity and (3) Intraoperative Flexibility." While the Stryker Rejuvenate Modular Hip System is not a metal-on-metal hip system there have been increasing reports of metal injuries at the location where the metal modular stem meets the metal neck of the device.

 

*Depuy Hip- In August of 2010, DePuy announced the recall of two of its hip replacement systems due to high failure rates in the DePuy ASR™ XL Acetabular System and DePuy ASR™ Hip Resurfacing System. Thousands of patients complained of a wide variety of issues, including pain when weight is applied, difficulty walking, loosening, inflammation and tumors, among others. Many patients have been forced to undergo painful revision surgeries to correct the problem. Another major concern with certain DePuy systems is their use of metal-on-metal components, including the DePuy ASR™ XL Acetabular System and the DePuy Pinnacle® Acetabular Cup System. While initially touted for their added stability and longer life, a growing body of evidence indicates that, as they loosen, the device releases microscopic bits of metal that get into and contaminate the bloodstream, eventually leading to a condition called metallosis.

 

*Biomet Magnum Hip– This is Biomet’s metal on metal hip system and has been known to produce metallosis for the patients that have received this implant. Yet to be recalled.

  

*Wright Medical Profemur/Conserve- This is another metal on metal hip system and has also been shown to produce metallosis. In addition to the metal on metal feature, this system has a modular neck design and was the predicate device to the Stryker Rejuvenate Modular discussed above.

  

*Smith & Nephew R3 MOM Hip– these cases are not as common as the BHR components that are protected because they were PMA. We also need to look for cases with the SMF modular stem. Yet to be recalled.

 

*Zimmer MOM Hips– Zimmer has multiple MOM products that include the Durom Cup, Metalsul Liners and the MMC cup. Yet to be Recalled.       

 

MEDICAL DEVICES - KNEES, MESH, IVC, MIRENA:      

 

*Zimmer Nexgen Flex knee- Orthopedic device manufacturer Zimmer has distributed a series of Flex knee replacement systems that appear to have a much higher failure rate than industry averages. The failure of the Zimmer Flex knees resulted in additional knee pain, loosening, less stability and, often, the need for painful revision surgeries. One of the more prominent issues has been the failure of the CR-Flex Porous Femoral component. It was designed to be installed without cement and to bond to the knee via natural bone growth. Many of these components failed to bond properly, indicating that the design may be flawed. Most knee replacements are expected to last for approximately 15 years. The CR-Flex has been shown to loosen in as little as two. 

 

*IVC Filter- Bard IVC filters are tiny blood clot filter devices that were designed to prevent blood clots from traveling from the lower body to the lungs.  Patients often are given a Bard IVC filter if they are deemed to be at significant risk of suffering from a pulmonary embolism and can't take anticoagulants. Bard Recovery Inferior Vena Cava filters, also known as Bard IVC filters and Bard G2 IVC filters, have been linked to a higher chance of failure and migration.  When the arms or struts of the Bard IVC filters rupture or break loose while they are still inside the body serious injury or even death may result.

*Mirena– This is a Bayer IUD product that includes the “morning after medication” which is contained in a reservoir for continual release. The product is recommended for placement up to 5 years and has been shown to experience product migration issues requiring surgical removal and other injuries.      

*Transvaginal Mesh— Transvaginal mesh is a synthetic or biologic material permanently implanted in women to repair pelvic organ prolapse (POP) or to support the urethra to treat urinary incontinence. Women might undergo the surgical procedure following birth to repair the weakened vaginal wall. However, the U.S. Food and Drug Administration (FDA) has found that transvaginal mesh, regardless of manufacturer, can expose patients to health risks such as the erosion of the product into surrounding areas of the pelvis and pelvic organs. Part of the product can become implanted as intended to strengthen the vaginal wall while some of it is not absorbed into the tissue. If complications arise as a result, removal of the implant can be complicated and costly. Other health issues could develop.

 

DRUGS:

 

*Tylenol- Johnson & Johnson, the manufacturer of Tylenol products, has experienced several recalls on various forms of Tylenol over the years. Tylenol has been linked to a high risk of liver failure and kidney failure, especially when taken by elderly or dehydrated people. The active ingredient in Tylenol, acetaminophen, is the main culprit for liver damage. Tylenol has posed significant health risks to consumers and patients ever since its creation. Johnson & Johnson has been forced to lower the maximum dosage for several Tylenol products because of the real possibility of "staggered overdoses." Over several successive days, too much acetaminophen causes more deaths due to liver damage than deaths due to deliberate suicides by a single overdose.

 

*Fosamax/Boniva- Fosamax/Boniva are prescribed for Osteoporosis and is in a class of drugs called bisphosphonates. Bisphosphonates halt the progression of one thinning by preventing bones from losing calcium and other minerals that keep them strong. Some bisphosphonate drugs also are used to treat cancer patients with bone-threatening high blood calcium levels and victims of Paget’s disease, a painful disorder that weakens bones. While Fosamax is prescribed to treat osteoporosis and reduce the risk of hip fractures and long bone fractures, the mechanism of action, which prevents bone turn-over, could make users vulnerable to subtrochanteric mid-shaft femur fractures. In addition to the low-energy femur fractures associated with Fosamax side effects, users have also reported deterioration of the bone in the jaw, hip, knees and shoulders, which can cause permanently disabling injuries.

 

*Actos- The diabetes medication Actos has been linked to increased risk of bladder cancer and of developing a condition called diabetic macular edema, which can cause blindness. Actos ("pioglitazone" in generic form) is made by Takeda Pharmaceuticals North America Inc. It is prescribed to control blood sugar in type 2 diabetes patients, but its heightened risk factors have been confirmed in multiple studies. The U.S. Food and Drug Administration (FDA) is taking the findings of these studies seriously. Takeda will be required to include the cancer warning on the drug's labeling soon.

*Yaz- Yaz is a birth control pill manufactured and marketed by Bayer HealthCare Pharmaceuticals. Shortly after Yaz hit the market, Bayer was forced to pull two of its ads because they overstated the benefits of taking the drug and failed to adequately warn potential users about the possible side effects, including severe blood clots, gallbladder and kidney damage and other issues.As a result of taking Yaz, young women were put at extreme risk of serious health complications. The excessive blood clotting caused some victims to suffer strokes or heart attacks, and others underwent emergency cholecystectomies to have their gallbladders removed.

 

 

*Pradaxa— Pradaxa is a blood thinner, or anticoagulant, used to reduce the risk of stroke in individuals with non-valvular atrial fibrillation. Anticoagulants can cause bleeding, but with previous drugs on the market, this bleeding could be treated. Pradaxa deaths are primarily caused by three types of bleeding: gastrointestinal, internal bleeding, or a brain hemorrhage. Internal bleeding cannot be seen and can occur throughout the body, leading to organ shutdown and death. Gastrointestinal bleeding is a type of internal bleeding that occurs in the digestive system. A brain hemorrhage occurs when an artery in the brain bursts. Each of these conditions are particularly dangerous because they can be hard to detect and, if left untreated, can lead to death.

 

Back to Elder Law Legal Updates